GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SpectraCure AB (OSTO:SPEC) » Definitions » Institutional Ownership

SpectraCure AB (OSTO:SPEC) Institutional Ownership : 0.02% (As of May. 04, 2025)


View and export this data going back to 2015. Start your Free Trial

What is SpectraCure AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SpectraCure AB's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SpectraCure AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SpectraCure AB's Float Percentage Of Total Shares Outstanding is 0.00%.


SpectraCure AB Institutional Ownership Historical Data

The historical data trend for SpectraCure AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SpectraCure AB Institutional Ownership Chart

SpectraCure AB Historical Data

The historical data trend for SpectraCure AB can be seen below:

2024-04-30 2024-05-31 2024-07-31 2024-08-31 2024-09-30 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.02 0.02

SpectraCure AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


SpectraCure AB Business Description

Traded in Other Exchanges
N/A
Address
Magistratsvagen 10, Lund, SWE, 22643
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.